Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature

E-ISSN： 1756-185x|21|2|362-372

ISSN： 1756-1841

Source： INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol.21, Iss.2, 2018-02, pp. : 362-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Literature: Rheumatoid Arthritis and Occupational Therapy

The British Journal of Occupational Therapy, Vol. 61, Iss. 1, 1998-01 ,pp. : 12-12

College of Occupational Therapists

Access to resources Recommend Favorite

Comparison of different biologic agents in patients with rheumatoid arthritis after failure of the first biologic therapy

By Strehblow Christoph

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 9-10, 2010-05 ,pp. : 225-229

Springer Publishing Company

Access to resources Recommend Favorite

Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease‐Modifying Therapy

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 5, 2015-05 ,pp. : 731-736

John Wiley & Sons Inc

Access to resources Recommend Favorite

Darier's disease and rheumatoid arthritis: a new association and a review of the literature

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 12, 2017-12 ,pp. : 2146-2147

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry

By Weaver Arthur L. Lautzenheiser Richard L. Schiff Michael H. Gibofsky Allan Perruquet James L. Luetkemeyer John Paulus Harold E. Xia H Amy Leff Jonathan A.

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 185-198

Informa Healthcare

Access to resources Recommend Favorite